PCRonline @ TCT 2021 - Get the international perspective!

Condensed take-home messages from the #TCT2021 LBTs

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

TCT 2021 - November 4-6, 2021

Mirvat Al Asnag, Nicola Ryan, Michele Pighi, Elad Asher, Francesco Costa, Ali Nazmi Calik, Panos Xaplanteris, Daniele Giacoppo, Dejan Milasinovic, Luis Ortega-Paz, Radoslaw Parma, Paola Redaelli, Giuseppe Biondi-Zoccai, Alessandro Sticchi and Jonathan Curio have reviewed a selection of major Late-breaking Clinical Trials and Science (LBTs) in Interventional Cardiology released at the 2021 Transcatheter Cardiovascular Therapeutics Congress (TCT 2021).

Late-breaking Clinical Trials and Science covered:

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG
FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI
SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk
PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk
CHOICE-CLOSURE: A Randomized Trial of Plug-Based Versus Suture-Based Large-Bore Vascular Closure
AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion
SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure
GUIDE-HF: A Randomized Trial of Hemodynamic-Guided Management of Heart Failure – Outcomes According to Ejection Fraction
TRISCEND: Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation - with an interview of Susheel Kodali
TRISCEND: Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

This independent TCT 2021 Coverage is available thanks to the unrestricted support of Shockwave IVL